ZLTQ:NGS-ZELTIQ Aesthetics Inc.

EQUITY | Medical Devices | Nasdaq Global Select

Last Closing

USD 56.48

Change

0.00 (0.00)%

Market Cap

USD 1.64B

Volume

3.12M

Analyst Target

USD 56.50
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

ZELTIQ Aesthetics Inc is a medical technology company. The Company is engaged in developing and commercializing products utilizing its proprietary controlled cooling technology platform.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

+0.14 (+0.10%)

USD 51.34B
ALGN Align Technology Inc

-3.28 (-1.05%)

USD 23.62B
BRKR Bruker Corporation

-1.61 (-1.96%)

USD 12.93B
SWAV Shockwave Medical Inc

+0.12 (+0.04%)

USD 12.34B
PODD Insulet Corporation

-3.08 (-1.84%)

USD 11.49B
MASI Masimo Corporation

-0.68 (-0.50%)

USD 7.14B
AXNX Axonics Modulation Technologie..

-0.10 (-0.15%)

USD 3.40B
IRTC iRhythm Technologies Inc

-5.16 (-4.43%)

USD 3.36B
QDEL Quidel Corporation

-1.13 (-2.77%)

USD 3.14B
LIVN LivaNova PLC

-0.84 (-1.50%)

USD 3.02B

ETFs Containing ZLTQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 271.33% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 271.33% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 27.59% N/A N/A N/A N/A
Dividend Return 27.59% N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 42.32% N/A N/A N/A N/A
Risk Adjusted Return 65.20% N/A N/A N/A N/A
Market Capitalization 1.64B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Devices) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 56.70 N/A N/A
Price/Book Ratio 3.41 N/A N/A
Price / Cash Flow Ratio 143.00 N/A N/A
Price/Free Cash Flow Ratio 115.20 N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike